News
Shortcuts from other journals
Chemotherapy prolongs survival after surgery for gastric cancer
BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7627.962-c (Published 08 November 2007) Cite this as: BMJ 2007;335:962S-1 is an oral chemotherapy agent that combines a prodrug of fluorouracil with two enzyme inhibitors—one to stop the active drug being degraded and the other to help protect against gastrointestinal toxicity. Japanese oncologists use it to treat advanced gastric cancer, and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.